Polynucleotides
Polynucleotides are injectable bio-stimulators which are commonly derived from trout or salmon DNA. They work at a deep level to repair the DNA of the skin cells and help to stimulate fibroblasts, promoting tissue repair, enhancing cell turnover, increasing elasticity, and stimulating collagen production.
- Improved skin tone and texture
- Anti-ageing properties – Reduces the appearance of lines and wrinkles
- Can help with hyperpigmentation
- Treats sun damage
- Reduction in blemishes and acne scarring
- Brighter complexion
- Increased skin hydration
- Detoxing effect against free radicals
- Helps to contour and tighten skin
Lumi Eyes – 3x treatments, each four weeks apart.
Nucleofill – 2-4x treatments, each four weeks apart.
Polynucleotides provide both immediate and progressive results. You may notice an immediate improvement in skin texture and hydration after the treatment. The full benefits become more apparent in the weeks following treatment as collagen production is stimulated.
Results last 6-12 months however this will vary from person to person depending on factors such as age and lifestyle.
Polynucleotide treatments use nucleotides to facilitate cellular repair and renewal while skin boosters are primarily composed of hyaluronic acid.
Polynucleotides offer a regenerative approach, inducing long-term skin improvements and structural healing from within. Meanwhile, skin boosters provide immediate hydration and enhance skin texture for a natural glow.
Polynucleotides and skin boosters work well together and can both be used for optimal skin revitalisation.
Please avoid the following:
- Strenuous exercise for 48 hours.
- Excessive sun exposure and swimming for 48 hours.
- Extreme temperatures such as heat (saunas, sunbeds) and extreme cold for a week post-treatment.
- Touching your face.
- Wearing makeup – wait at least 24 hours after your treatment.
- Alcohol for 24 hours – stay hydrated.
Facials, laser therapy, facial waxing or treatments such as microdermabrasion / dermaplaning for 2 weeks post-treatment